Treatment of keloid

Not yet recruiting

• Conditions: Other hypertrophic disorders of the skin,

• Registration Number: CTRI/2022/12/048089

Brief Summary

Consent will be taken from the patient after explaining the study to the patient. Using a standard proforma, details regarding history, clinical examination and dermoscopic findings will be recorded. The POSAS questionnaire will be administered. Photograph of the lesion will be taken. The treatment for the keloid will be advised by the treating dermatologist and will be given by the respective doctor. Patient will be followed up after 4-8 weeks for 4 sessions and on each visit the clinical examination, dermoscopy of the lesion will be done and the questionnaire will be administered. There will be no extra cost to the patient

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-07-12
• Study Start: 2022-12-14

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Patients who are undergoing treatment for keloid.

Exclusion Criteria

Those patients who do not give consent for their lesion to be photographed and those who are not willing to take the POSAS questionnaire.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the etiology and clinical profile of patients with keloid	30/09/24

Secondary Outcome Measures

Name	Time	Method
To study the dermoscopic features of keloid	30/09/24
To assess the patient satisfaction with respect to the different treatment modalities using the POSAS questionnaire	30/09/24

Trial Locations

Locations (1)

Kasturba Hospital; 🇮🇳 Udupi, KARNATAKA, India

Kasturba Hospital

🇮🇳Udupi, KARNATAKA, India

Dr Priya Bhesaniya

Principal investigator

8105078072

priya.bhesaniya95@gmail.com